SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 88 filers reported holding SURFACE ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $493 | +11.0% | 567,400 | -10.6% | 0.00% | 0.0% |
| Q1 2023 | $444 | -24.2% | 635,000 | -11.1% | 0.00% | 0.0% |
| Q4 2022 | $586 | -99.9% | 714,155 | -27.5% | 0.00% | 0.0% |
| Q3 2022 | $1,025,000 | -24.1% | 985,343 | +19.6% | 0.00% | -50.0% |
| Q2 2022 | $1,351,000 | -23.2% | 823,690 | +37.6% | 0.00% | 0.0% |
| Q1 2022 | $1,760,000 | -33.2% | 598,628 | +56.8% | 0.00% | -33.3% |
| Q3 2020 | $2,634,000 | -28.2% | 381,737 | -31.8% | 0.00% | 0.0% |
| Q2 2020 | $3,669,000 | +1087.4% | 559,337 | +238.3% | 0.00% | – |
| Q1 2020 | $309,000 | -13.2% | 165,342 | -12.6% | 0.00% | – |
| Q4 2019 | $356,000 | +408.6% | 189,100 | +284.3% | 0.00% | – |
| Q3 2019 | $70,000 | +7.7% | 49,200 | +112.1% | 0.00% | – |
| Q2 2019 | $65,000 | – | 23,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 2,945,453 | $22,297,000 | 7.41% |
| ACT CAPITAL MANAGEMENT, LLC | 170,500 | $1,291,000 | 0.67% |
| SummerHaven Investment Management, LLC | 128,078 | $970,000 | 0.57% |
| Parkman Healthcare Partners LLC | 248,267 | $1,879,000 | 0.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $379,000 | 0.21% |
| C M BIDWELL & ASSOCIATES LTD | 33,030 | $250,000 | 0.17% |
| ARK Investment Management | 4,618,354 | $34,961,000 | 0.08% |
| Knights of Columbus Asset Advisors LLC | 114,594 | $867,000 | 0.08% |
| Orbimed Advisors | 909,666 | $6,886,000 | 0.08% |
| HighVista Strategies LLC | 13,932 | $105,000 | 0.07% |